The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Anderson, Emma L ^a   Howe, Laura D ^a   Jones, Hayley E ^a   Higgins, Julian P T ^a,b   Lawlor, Debbie A ^a   Fraser, Abigail ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; ASIA; BIOPSY; BODY MASS; CHILD; CHILDHOOD DISEASE; CHILDHOOD OBESITY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ECHOGRAPHY; GEOGRAPHIC AND GEOLOGICAL PHENOMENA; HUMAN; INTERMETHOD COMPARISON; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; SAMPLE SIZE; SEX DIFFERENCE; SYSTEMATIC REVIEW; FEMALE; HEALTH SURVEY; INFANT; MALE; META ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PRESCHOOL CHILD; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; BIOMARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84949745307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140908     Document Type: Article

References (31)

1. Bellentani S, Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol 2009; 8 Suppl 1:S4-S8. PMID: 19381118
2. Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008; 28:370-379. doi: 10.1055/s-0028-1091981 PMID: 18956293
3. Leevy CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine (Baltimore) 1962; 41:249-276.
4. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of Fatty Liver in Children and Adolescents. Pediatrics 2006; 118:1388-1393. PMID: 17015527
5. Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 2008; 28:386-395. doi: 10.1055/s-0028-1091983 PMID: 18956295
6. Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013; 57:1357-1365. doi: 10.1002/hep.26156 PMID: 23175136
7. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53:372-384. doi: 10.1016/j.jhep.2010. 04.008 PMID: 20494470
8. Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci 1980; 12:1-58. PMID: 6104563
9. Lott J, Olf P. Alanine and aspartate aminotransferase (ALT and AST). Clinical enzymology: a case-oriented approach. Chicago: Year Book Medical Publishers, 1986:111-138.
10. Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N et al. SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease. Gastroenterology 2010; 138:1357-1364. doi: 10.1053/j.gastro.2009.12.052 PMID: 20064512
11. Park HN, Sinn DH, Gwak GY, Kim JE, Rhee SY, Eo SJ et al. Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease. Liver Int 2012; 32:937-944. doi: 10.1111/j.1478-3231.2011.02749.x PMID: 22260521
12. Lockitch G, Halstead AC, Albersheim S, MacCallum C, Quigley G. Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. Clin Chem 1988; 34:1622-1625. PMID: 3402068
13. Zheng MH, Shi KQ, Fan YC, Liu WY, Lin XF, Li LF et al. Upper limits of normal for serum alanine aminotransferase levels in Chinese Han population. PLoS One 2012; 7:e43736. doi: 10.1371/journal.pone. 0043736 PMID: 22962588
14. Prati D, Taioli E, Zanella A, Della TE, Butelli S, Del VE et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137:1-10. PMID: 12093239
15. Fishbein MH, Miner M, Mogren C, Chalekson J. The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis. Journal of Pediatric Gastroenterology and Nutrition 2003;2002/12/25:54-61. PMID: 12499997
16. Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005; 4:10. PMID: 16375767
17. Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005; 4:10. PMID: 16375767
18. Papadia FS, Marinari GM, Camerini G, Murelli F, Carlini F, Stabilini C et al. Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. Obes Surg 2004; 14:952-958. PMID: 15329185
19. Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr 2007; 96:542-547. PMID: 17306008
20. Radetti G, Kleon W, Stuefer J, Pittschieler K. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Acta Paediatr 2006; 95:833-837. PMID: 16801180
21. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54:1082-1090. doi: 10.1002/hep.24452 PMID: 21618575
22. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 2011; 21:87-97. doi: 10.1007/s00330-010-1905-5 PMID: 20680289
23. Hesham A-K. Nonalcoholic fatty liver disease in children living in the obeseogenic society. World J Pediatr 2009; 5:245-254. doi: 10.1007/s12519-009-0048-8 PMID: 19911138
24. Angulo P. Obesity and Nonalcoholic Fatty Liver Disease. Nutrition Reviews 2007; 65:S57-S63. PMID: 17605315
25. Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011; 53:800-809. doi: 10.1002/hep.24097 PMID: 21374659
26. Trikalinos TA, Trow P, Schmid CH. Simulation-Based Comparison of Methods for Meta-Analysis of Proportions and Rates. Methods Research Reports 2013.
27. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health 2013; 67:974-978. doi: 10.1136/jech-2013-203104 PMID: 23963506
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560. PMID: 12958120
29. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ 2011; 342:d549. doi: 10.1136/bmj.d549 PMID: 21310794
30. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000; 53:1119-1129. PMID: 11106885
31. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Statist Med 2002; 21:1559-1573.